Pfizer

Showing 15 posts of 894 posts found.

Pfizerline image

Pfizer begins using ‘digital’ reps

September 24, 2013
Medical Communications, Sales and Marketing Pfizer, online, pfizerline, reps

Pfizer has begun using digital drug representatives to market medicines, leaving the decision as to whether they want to see …

Pfizer image

Pfizer launches trial data sharing service

September 23, 2013
Medical Communications, Sales and Marketing Pfizer, blue button

Pfizer has launched a first-of-its-kind project that enables patients who have participated in clinical trials the ability to download their …

Regeneron appoints senior VP from Pfizer

September 11, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, Regeneron, landry

Regeneron Pharmaceuticals has hired Robert Landry from Pfizer to be its senior vice president and chief financial officer.  Landry will …

Richard Bergström, EFPIA, all trials, ema

EFPIA slams EMA data proposals

September 10, 2013
Research and Development, Sales and Marketing AZ, EFPIA, EMA, GSK, Pfizer, Roche

The intense debate over how pharma should make trial data available has taken another turn as a major European industry …

NICE image

NICE queries pharma R&D costs

September 5, 2013
Research and Development, Sales and Marketing Dillon, NICE, Pfizer, R&D

NICE has questioned whether pharma really spends as much as it says it does on bringing new treatments to market …

pfizer image

Pfizer joins Amazon-like R&D network

August 30, 2013
Medical Communications Assay Depot, Pfizer, amazon

Pfizer has become the latest big pharma firm to sign up to Assay Depot, the Amazon-like virtual laboratory. The US …

xalkori image

Price cut not enough for Pfizer’s Xalkori

August 16, 2013
Sales and Marketing NICE, Pfizer, Xalkori, lung cancer

In final draft guidance NICE has rejected Pfizer’s new lung cancer drug Xalkori because of its high cost. The Institute …

Pfizer image

Lipitor competition holds Pfizer back

July 31, 2013
Sales and Marketing Lipitor, Pfizer, Prevnar, Q2

Pfizer’s revenues in the second quarter of 2013 fell 7% year-on-year, in part due to the loss of patent in …

January deadline for Pfizer restructure

July 30, 2013
Research and Development, Sales and Marketing Pfizer, patent, restructure

Pfizer is to restructure operations from January 2014 in a bid to make its business more responsive to patient and …

pfizer image

NICE rejects Pfizer blood cancer drug

July 16, 2013
Sales and Marketing BMS, CML, NICE, Pfizer, bosulif

NICE is not recommending Pfizer’s blood cancer drug Bosulif due to uncertainties over its cost effectiveness and survival benefit. In …

Irish eyes smiling as Pfizer plans $130m investment

July 15, 2013
Manufacturing and Production IDA, Pfizer, cork, grange

The company has said it will spend $100m upgrading its Grange Castle site in Dublin and $30m at Ringaskiddy in …

novartis image

Novartis compound beats Enbrel

July 9, 2013
Sales and Marketing Enbrel, Novartis, Pfizer, skin

One of Novartis’ investigational drugs has beaten Pfizer’s Enbrel in a head-to-head Phase III psoriasis study and is on course …

eliquis image

VTE boost for Eliquis

July 2, 2013
Research and Development, Sales and Marketing AMPLIFY, BMS, DVT, Eliquis, Pfizer

Bristol-Myers Squibb and Pfizer’s oral blood thinner Eliquis is as efficient as standard of care and causes less bleeding in …

The Gateway to Local Adoption Series

Latest content